Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
New study finds association between OSA and subclinical myocardial injury

New study finds association between OSA and subclinical myocardial injury

OPTIMISTIC study aims to reduce avoidable hospitalizations, increase access to palliative care

OPTIMISTIC study aims to reduce avoidable hospitalizations, increase access to palliative care

Canadian Partnership Against Cancer, Heart and Stroke Foundation to improve health of Canadians

Canadian Partnership Against Cancer, Heart and Stroke Foundation to improve health of Canadians

Flu vaccine may also reduce risk of heart attack by 50% among people who had heart attack

Flu vaccine may also reduce risk of heart attack by 50% among people who had heart attack

Influenza vaccination linked with reduced risk of adverse cardiovascular events

Influenza vaccination linked with reduced risk of adverse cardiovascular events

EvergreenHealth named one of America's 100 Best Hospitals in three specialty areas

EvergreenHealth named one of America's 100 Best Hospitals in three specialty areas

Cedars-Sinai wins national consumer award for providing quality medical care, staff in LA region

Cedars-Sinai wins national consumer award for providing quality medical care, staff in LA region

FDA approves Iroko Pharmaceuticals’ ZORVOLEX capsules

FDA approves Iroko Pharmaceuticals’ ZORVOLEX capsules

Research roundup: Less savings needed for retirement health expenses; falls as a predictor of surgical outcomes

Research roundup: Less savings needed for retirement health expenses; falls as a predictor of surgical outcomes

Oral nutritional supplements linked with decreased probability of 30-day hospital readmission

Oral nutritional supplements linked with decreased probability of 30-day hospital readmission

ARIAD discontinues Phase 3 EPIC trial of Iclusig in patients with chronic myeloid leukemia

ARIAD discontinues Phase 3 EPIC trial of Iclusig in patients with chronic myeloid leukemia

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

Cardiometabolic risk high for schizophrenia patients

Cardiometabolic risk high for schizophrenia patients

Proteins in CSF predict cognitive impairment before onset of disease

Proteins in CSF predict cognitive impairment before onset of disease

Researchers develop new tool to quantify myocardial damage in heart attack patients

Researchers develop new tool to quantify myocardial damage in heart attack patients

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Respicardia awarded U.S. Healthcare Product of the Year for remede System

Respicardia awarded U.S. Healthcare Product of the Year for remede System

Non-Hispanic black, Hispanic patients less likely to experience metabolic syndrome remission

Non-Hispanic black, Hispanic patients less likely to experience metabolic syndrome remission

UC researchers receive $2.1M grant from NIH to study molecular mechanisms of muscle fatigue

UC researchers receive $2.1M grant from NIH to study molecular mechanisms of muscle fatigue

WHO: Iron deficiency causes loss of 48,225 disability-adjusted life-years worldwide

WHO: Iron deficiency causes loss of 48,225 disability-adjusted life-years worldwide

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.